Brief sigmoidoscopy provides 21-year colorectal cancer risk reduction in men

Lancet Gastroenterol Hepatol. 2024 Sep;9(9):777-779. doi: 10.1016/S2468-1253(24)00199-7. Epub 2024 Jul 20.

Authors

Michael Bretthauer¹, Nastazja D Pilonis²

Affiliations

¹ Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, 0318 Oslo, Norway. Electronic address: michael.bretthauer@medisin.uio.no.
² Clinical Effectiveness Research Group, University of Oslo and Oslo University Hospital, 0318 Oslo, Norway; Department of Gastroenterological Oncology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland.

PMID: 39038481
DOI: 10.1016/S2468-1253(24)00199-7

No abstract available

MeSH terms

Colorectal Neoplasms* / diagnosis
Colorectal Neoplasms* / epidemiology
Colorectal Neoplasms* / prevention & control
Early Detection of Cancer / methods
Humans
Male
Middle Aged
Risk Reduction Behavior
Sigmoidoscopy*